Phase
Condition
Addictions
Alcohol Dependence
Alcohol Use Disorder
Treatment
Placebo to match sunobinop
Sunobinop
Clinical Study ID
Study Summary
Eligibility Criteria
Inclusion
Key Inclusion Criteria include:
Male and female age ≥18 years.
Diagnosis of moderate or severe alcohol use disorder.
Currently seeking treatment for alcohol use disorder.
Has 4 or more heavy drinking days (HDD) in each of the 4 weeks prior to baseline visit.
Key Exclusion Criteria include:
- Subjects that meet current DSM-5 criteria for moderate or severe substance use disorder other than alcohol and nicotine.
Other protocol-specific inclusion and exclusion criteria may apply.
Study Design
Connect with a study center
Bio Terra Med SRL
Bucharest, 010701
RomaniaSite Not Available
Cabinet Medical Individual Dr. Andreea Popa
Bucharest, 050802
RomaniaSite Not Available
Spitalul Universitar De Urgenta Militar Central "Dr. Carol Davila"
Bucharest, 010825
RomaniaSite Not Available
Cabinet Medical Individual Dr. Andreea Popa
Bucharest 683506, 050802
RomaniaActive - Recruiting
Spitalul Universitar De Urgenta Militar Central "Dr. Carol Davila"
Bucharest 683506, 010825
RomaniaActive - Recruiting
Belmont Medical Office
Brooklyn, New York 11212
United StatesSite Not Available
Ohio Clinical Trials
Columbus, Ohio 43212
United StatesSite Not Available
Inquest Clinical Research
Baytown, Texas 77521
United StatesSite Not Available
Cebis Usa, Llc
Houston, Texas 77074
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.